Stay updated on Pembrolizumab Combo With Local Ablation in HCC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo With Local Ablation in HCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo With Local Ablation in HCC Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    New sections for user guidance (How to Read a Study Record, Common Questions, How to Join a Study) and a No longer looking for participants notice were added, while the Intervention/Treatment header was standardized. The sponsor designation was updated to Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest and the page revision shows v3.6.0 (replacing v3.5.5).
    Difference
    0.5%
    Check dated 2026-06-12T16:39:58.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The revision label on the page was updated from v3.5.4 to v3.5.5, signaling a new revision of the page content; this appears to be an internal version update.
    Difference
    0.1%
    Check dated 2026-06-05T12:14:54.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    No Change Detected
  5. Check
    30 days ago
    Change Detected
    Summary
    Revision: v3.5.4 is now shown on the page, replacing the previous v3.5.3. This reflects an updated revision of the study record.
    Difference
    0.1%
    Check dated 2026-05-15T05:48:33.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    This updates the ClinicalTrials.gov page’s revision/version indicator from v3.5.2 to v3.5.3, reflecting a platform release rather than a change to the underlying study information.
    Difference
    0.1%
    Check dated 2026-04-24T06:21:42.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2 and removed Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T02:38:54.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    Results posted with expanded outcome measures (ORR, TTR, Recurrence Free Survival, OS) and biomarker analyses, plus related study documents.
    Difference
    2%
    Check dated 2026-03-26T11:30:48.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo With Local Ablation in HCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo With Local Ablation in HCC Clinical Trial page.